Health Care Companies By Enterprise Value

Current Valuation
Current ValuationEfficiencyMarket RiskExp Return
1LLY Eli Lilly and
782.5 B
 0.07 
 2.02 
 0.14 
2UNH UnitedHealth Group Incorporated
520.24 B
 0.02 
 1.90 
 0.03 
3ABBV AbbVie Inc
430.85 B
 0.16 
 1.40 
 0.22 
4JNJ Johnson Johnson
406.44 B
 0.16 
 1.15 
 0.19 
5NVO Novo Nordisk AS
352.77 B
(0.09)
 2.85 
(0.25)
6MRK Merck Company
258.62 B
(0.10)
 1.82 
(0.18)
7AZN AstraZeneca PLC ADR
257.91 B
 0.16 
 1.17 
 0.19 
8NVS Novartis AG ADR
236.15 B
 0.20 
 1.35 
 0.27 
9ABT Abbott Laboratories
226.17 B
 0.11 
 1.48 
 0.16 
10TMO Thermo Fisher Scientific
221.02 B
(0.01)
 1.56 
(0.02)
11AMGN Amgen Inc
217.9 B
 0.19 
 1.51 
 0.29 
12PFE Pfizer Inc
191.42 B
(0.03)
 1.18 
(0.03)
13ISRG Intuitive Surgical
172.43 B
(0.02)
 2.23 
(0.04)
14DHR Danaher
166.13 B
(0.07)
 1.82 
(0.12)
15BMY Bristol Myers Squibb
164.27 B
 0.04 
 1.64 
 0.07 
16BSX Boston Scientific Corp
159.66 B
 0.14 
 1.47 
 0.20 
17CVS CVS Health Corp
156.46 B
 0.27 
 2.62 
 0.71 
18SNY Sanofi ADR
153.05 B
 0.17 
 1.36 
 0.23 
19SYK Stryker
150.71 B
 0.02 
 1.28 
 0.02 
20GILD Gilead Sciences
148.49 B
 0.15 
 1.60 
 0.25 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.